Tags: Drug.
Panitumumab (INN) formerly ABX-EGF is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor EGFR ErbB-1 and HER1 in humans). Panitumumab is manufactured by Amgen and marketed as Vectibix. It was originally developed by Abgenix Inc.In 2014 Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab.